Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
SARS-CoV-2 infection of carotid arteries may explain vascular involvement in COVID-19

SARS-CoV-2 infection of carotid arteries may explain vascular involvement in COVID-19

Researchers identify a potential target for small cell lung cancer

Researchers identify a potential target for small cell lung cancer

MD Anderson and Astex Pharmaceuticals partner to accelerate clinical evaluation of leukemia therapies

MD Anderson and Astex Pharmaceuticals partner to accelerate clinical evaluation of leukemia therapies

Researchers identify new mechanism that causes leukemia

Researchers identify new mechanism that causes leukemia

Combination regimen improves overall survival in certain patients with AML

Combination regimen improves overall survival in certain patients with AML

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia

ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia

Study could refine treatment recommendations for younger adult patients with acute leukemia

Study could refine treatment recommendations for younger adult patients with acute leukemia

Study reveals impact of TP53 gene mutations on MDS severity

Study reveals impact of TP53 gene mutations on MDS severity

Study sheds light on potential new treatment approach in AML patients

Study sheds light on potential new treatment approach in AML patients

Researchers identify specific target sites for DNA methylases

Researchers identify specific target sites for DNA methylases

Mapping immune landscape of hematological malignancies may help improve cancer therapies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

New nanoconjugate blocks dissemination of tumor cells in animal models of acute myeloid leukemia

New nanoconjugate blocks dissemination of tumor cells in animal models of acute myeloid leukemia

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers discover new and improved way to treat poor-prognosis blood cancer

Researchers discover new and improved way to treat poor-prognosis blood cancer

Researchers call for caution of using CAR-T immunotherapy against AML

Researchers call for caution of using CAR-T immunotherapy against AML

Two potent small molecules appear to suppress tumor growth in multiple cancers

Two potent small molecules appear to suppress tumor growth in multiple cancers

New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

Researchers discover key gene essential for survival of leukemia stem cells

Researchers discover key gene essential for survival of leukemia stem cells

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases